CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Screening for Cognitive Impairment in Asymptomatic Community-Dwelling Older Adults: Clinical Utility and Guidelines

Last updated: October 13, 2020
Project Number: RA1143-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical utility of screening for cognitive impairment in asymptomatic community-dwelling older adults?
  2. What are the evidence-based guidelines regarding the use of screening for cognitive impairment in asymptomatic community-dwelling older adults?

Key Message

One systematic review with meta-analysis and one randomized controlled trial were identified regarding the clinical utility of screening for cognitive impairment in asymptomatic community-dwelling older adults. Six evidence-based guidelines were identified regarding the use of screening for cognitive impairments in asymptomatic community-dwelling older adults.